HA
HZNP

H2O AM’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

H2O AM’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-114,047
Closed -$3.1M – 111
2019
Q3 		$3.1M Buy
+114,047
New +$2.95M 0.53% 45

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

H2O AM's HZNP Position: Q4 2019 in Review

H2O AM sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2019, closing a stake of 114,047 shares — an estimated $3.1M sold.

H2O AM first reported a position in HZNP in Q3 2019 and held it in 1 quarter. The position peaked at $3.1M in Q3 2019. 281 funds tracked by Wall St. Rank hold HZNP as of Q4 2019.

  • H2O AM reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2019 after selling out during the quarter.
  • H2O AM sold 114,047 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2019, an estimated $3.1M.
  • H2O AM first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2019 and held it in 1 quarter.
  • H2O AM's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.1M in Q3 2019.
  • 281 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2019.

Based on H2O AM's 13F filing for Q4 2019, filed 14 Feb 2020.